|
Acesulfame Potassium
6-Methyl-1,2,3-oxathiazine-4(3H)-one-2,2-dioxide potassium salt. 3,4-Dihydro-6-methyl-1,2,3-oxathiazine-4-one-2,2-dioxide potassium salt » Acesulfame Potassium contains not less than 99.0 percent and not more than 101.0 percent of C4H4NO4SK, calculated on the dried basis.
Packaging and storage
Preserve in a well-closed container, and protect from light. Store at room temperature.
Identification
B:
A solution (1 in 10) responds to the tests for Potassium
Acidity or alkalinity
Dissolve 4.0 g in 20 mL of carbon dioxide-free water, add 0.1 mL of bromothymol blue TS. If the solution is yellow, not more than 0.2 mL of 0.01 N sodium hydroxide is required to produce a blue color. If the solution is blue, not more than 0.2 mL of 0.01 N hydrochloric acid is required to produce a yellow color.
Loss on drying
Limit of fluoride
[noteUse plasticware throughout this test.]
Buffer solution
Dissolve 210 g of citric acid monohydrate in 400 mL of water. Adjust with concentrated ammonia to a pH of 7.0, dilute with water to 1000 mL, and mix (Solution A). Dissolve 132 g of dibasic ammonium phosphate in water, dilute with water to 1000 mL, and mix (Solution B). To a suspension of 292 g of edetic acid in about 500 mL of water, add about 200 mL of ammonium hydroxide, and mix to dissolve (Solution C). Adjust with ammonium hydroxide to a pH between 6 and 7, dilute with water to make 1000 mL, and mix. Mix equal volumes of Solution A, Solution B, and Solution C, and adjust with ammonium hydroxide to a pH of 7.5.
Standard stock solution
Weigh accurately about 0.442 g of sodium fluoride, previously dried at 300
Standard solutions
Into separate 50-mL volumetric flasks, pipet 0.5, 1.0, 1.5, and 3.0 mL of the Standard stock solution, add 15.0 mL of Buffer solution to each volumetric flask, dilute with water to volume, and mix.
Test solution
Place about 3 g of Acesulfame Potassium, accurately weighed, in a 50-mL volumetric flask, dissolve in water, add 15.0 mL of Buffer solution, dilute with water to volume, and mix.
Procedure
Concomitantly measure the potential (see Titrimetry
5(C/W)
in which C is the fluoride concentration, in µg per mL, from the standard curve; and W is the weight, in mg, of Acesulfame Potassium taken to prepare the Test solution: not more than 0.0003% of fluoride is found.
Heavy metals, Method I
Chromatographic purity
Tetrabutylammonium hydrogen sulfate solution
Dissolve 3.3 g of tetrabutylammonium hydrogen sulfate in 1 L of water, and mix.
Mobile phase
Prepare a mixture of Tetrabutylammonium hydrogen sulfate solution and acetonitrile (3:2), filter, and degas. Make adjustments if necessary (see System Suitability under Chromatography
System suitability solution
Dissolve suitable quantities of USP Acesulfame Potassium RS and ethylparaben in water to obtain a solution containing about 2 µg per mL of each.
Standard solution
Dissolve an accurately weighed quantity of USP Acesulfame Potassium RS in water, and dilute quantitatively, and stepwise if necessary, with water to obtain a solution having a known concentration of about 0.2 µg per mL.
Test solution
Transfer about 100 mg of Acesulfame Potassium, accurately weighed, to a 10-mL volumetric flask, dissolve in and dilute with water to volume, and mix.
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms for a run time not less than 3 times the retention time of the acesulfame potassium peak, and measure the area responses of the peaks: the response of any peak at a retention time other than that of acesulfame potassium in the chromatogram obtained from the Test solution does not exceed the response of the acesulfame potassium peak in the chromatogram obtained from the Standard solution (0.002%).
Assay
Dissolve about 150 mg of Acesulfame Potassium, accurately weighed, in 50 mL of glacial acetic acid, and titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically (see Titrimetry
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1150
Pharmacopeial Forum: Volume No. 31(3) Page 811
|